Happy International Day of Women and Girls in Science! Thrilled to support the ACS's work to support incredible women scientists and those who will become scientists. https://t.co/e2XDYKythu #researchers#womeninscience
Excited to share our latest work! KLF5 is normally found in prostate basal cells, and absent in primary prostate tumors. However, endocrine therapies can up-regulate KLF5 in CRPC. This sets off a clash with AR for basal vs. luminal cell identity! https://t.co/LmoPYfiH39
This years Leland W.K. Chung Lecture will be given by Dr. Padmanee Sharma, MD, PhD from MD Anderson, TX! Dr. Sharma will present "Immune Response and Immunotherapy in Urological Diseases" at the 2021 SBUR Annual Meeting!
Big news! #SBUR21 is going fully virtual. Hear all about the latest #UroRes from the comfort of your (home) office, couch, or wherever WiFi finds you. Details on registration and our preliminary program can be found here: https://t.co/syFgClhk9g
PSMA PET now part of the NCCN guidelines 2022!
Great for patients !
"the Panel does not feel that conventional imaging is a necessary prerequisite to PSMA-PET and that PSMA-PET can serve as an equally effective, if not more effective front-line imaging tool for these patients."
Truly an honor to work with this remarkable leader @NBDavisMD who is our new VP for Cancer Care Network and Strategy! @VUMC_Cancer @VUMC_Medicine @VUMC_MD and fitting to recognize in this #WIMMonth@TheCancerLetter
Proud of this great work by Ivana Grbesa @augelloma@deli_liu and many others defining AR chromatin landscape in normal prostate cells and impact of SPOP mutations. Thanks to all collaborators! Tweetorial to follow! @PCF_Science@DamonRunyon
https://t.co/XN3nzi6kA0
I am really thrilled to see @benhopark take up the reins as @VUMC_Cancer Deputy Director. His style and energy are going to be fantastic for our cancer center! Congrats, Ben! @TheCancerLetter
The Dept of Cell and Developmental Biology at Vanderbilt is beginning a search for new junior faculty this fall. This is an open search - looking for exceptional scientists in any area of cell/dev biology.
Two castration resistant prostate cancer cell lines with deep molecular/phenotypic characterization to add to the PCa research armamentarium! Congrats @M_Haffner, @bhamidipati97 and team! https://t.co/iNNmxAAFbd
Long pandemic winter meant time to write reviews! This one with @EAntonarakis on a tough but important topic: “Targeting the spectrum of immune checkpoints in prostate cancer” https://t.co/fDkXhxdJeA @Hopkins_HemOnc